Strategic Priority Areas
Critical focus areas for the future of health in Brazil
Where Agenscia focuses its action
Agenscia structures its work around strategic areas considered critical for the future of health in Brazil.
These areas reflect national priorities where applied science, technological sovereignty, and health system impact can converge in a structured, sustainable, and scalable way.
Criteria guiding our strategic priorities
Agenscia’s work is guided by clear strategic criteria, defined based on the structural needs of the Brazilian health system, available scientific evidence, and the importance of national technological sovereignty.
These criteria inform the selection of priority areas, institutional partnerships, and long-term decisions throughout the foundational phase.
Based on these criteria, Agenscia focuses on the following strategic priority areas:
Precision Medicine
Better treatment begins with deeper understanding
Read more
Precision medicine is essential for delivering more effective, safer, and population-adapted diagnostics and therapies. Progress in this area helps reduce inefficiencies, improve clinical outcomes, and strengthen national capabilities in genomics, bioinformatics, and molecular biology applied to health.
Biosensing & Nanobiotechnology
Early diagnosis is a system-level strategy
Read more
Micro- and nanosensor technologies enable continuous monitoring, early diagnosis, and new approaches to personalized care. This area is strategic for expanding access to advanced solutions, reducing healthcare costs, and integrating scientific innovation with digital health and connected devices.
Gene and Regenerative Therapies
Advancing health requires new therapeutic foundations
Read more
Cell, gene, and regenerative therapies represent a structural shift in the treatment of chronic, rare, and degenerative diseases. Developing national capabilities in this area is essential to ensure access, regulatory security, and long-term sustainability.
Artificial Intelligence & Big Data in Health
Well-used data can transform entire systems
Read more
The strategic application of artificial intelligence and large-scale data analysis transforms healthcare management, diagnosis, and research. This area is critical to increase efficiency, support clinical decision-making, and strengthen national capabilities in digital health and applied data science.
Strategic Inputs and Productive Autonomy
Health sovereignty begins with production capacity
Read more
Dependence on external sources for essential health inputs weakens system resilience. Developing domestic capacity for producing reagents, biomaterials, vectors, and strategic sensors is essential for health security, scientific continuity, and sustainable development.
These areas guide the construction of Agenscia’s institutional pipeline and structure its work in strategic intelligence, talent development, technology maturation pathways, and productive strengthening.
Agenscia’s Innovation Pipeline
Health innovation moves through stages: Discovery → Development → Preclinical → Clinical → Adoption
How strategic areas connect to the pipeline
Each of Agenscia’s strategic areas operates across specific stages of the health innovation pipeline.
This alignment enables more precise allocation of efforts—focusing where scientific, clinical, and systemic impact potential is highest.
- Precision Medicine → Preclinical and Clinical
- Biosensing & Nanobiotechnology → Development and Preclinical
- Gene and Regenerative Therapies → Development, Preclinical, and Clinical
- Artificial Intelligence & Big Data → Development, Clinical, and Adoption
- Strategic Inputs and Productive Autonomy → Development and Adoption
This structure guides how Agenscia connects knowledge, technology, and productive capacity across the full innovation journey.
